In the setting of BRAFi resistance, it is recognized that BRAFi can lead to paradoxical activation of the MAPK pathway in non-mutant cells in the TME, including in TAMs, driving these cells to an immunosuppressive VEGF-secreting state, which in turn reactivates the MAPK pathway in melanoma cells [131]. This evidence concerns the gene VEGFA and melanoma.